Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/jci.insight.198360

Chemotherapy-induced reactive myelopoiesis promotes expansion of immunosuppressive neutrophil-like monocytes in mice and humans

Huidong Shi,1 Zhi-Chun Ding,1 Ogacheko D. Okoko,2 Xin Wang,1 George Zhou,1 Yan Ye,1 Md Yeashin Gazi,1 Caitlin Brandle,1 Lirong Pei,1 Rafal Pacholczyk,1 Catherine C. Hedrick,1 Locke J. Bryan,1 and Gang Zhou1

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Shi, H. in: PubMed | Google Scholar |

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Ding, Z. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Okoko, O. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Wang, X. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Zhou, G. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Ye, Y. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Gazi, M. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Brandle, C. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Pei, L. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Pacholczyk, R. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Hedrick, C. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Bryan, L. in: PubMed | Google Scholar

1Georgia Cancer Center, Augusta University, Augusta, United States of America

2Georgia Cancer Center, Augusta Univeristy, Augusta, United States of America

Find articles by Zhou, G. in: PubMed | Google Scholar

Published April 7, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.198360.
Copyright © 2026, Shi et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 7, 2026 - Version history
View PDF
Abstract

Cytotoxic chemotherapy primarily targets rapidly proliferating cancer cells but also depletes normal myeloid cells. The resulting cell loss triggers reactive myelopoiesis, a compensatory process in which hematopoietic stem and progenitor cells (HSPCs) in the bone marrow (BM) regenerate myeloid lineages. We previously showed that the alkylating agent cyclophosphamide (CTX) induces myelopoiesis leading to the expansion of immunosuppressive monocytes in mice. However, the molecular features and clinical relevance of these cells remain poorly understood. Here, we report the emergence of immunosuppressive monocytes in the peripheral blood of lymphoma patients receiving CTX-containing chemotherapy. To gain mechanistic insight into CTX-induced myelopoiesis, we performed single-cell RNA sequencing (scRNA-seq) and assay for transposase-accessible chromatin using sequencing (ATAC-seq) on BM monocytes from CTX-treated mice. These analyses revealed a heterogeneous monocyte population and demonstrated that CTX skews myelopoiesis toward the generation of neutrophil-like monocytes (NeuMo). Moreover, CTX-induced NeuMo cells, enriched within the CXCR4⁺CX3CR1⁻ monocyte subset, exhibited potent T-cell suppressive activity. Using the NeuMo gene signature, reanalysis of public scRNA-seq datasets identified a transcriptionally similar monocyte subset in chemotherapy-treated cancer patients. Collectively, our findings suggest that the expansion of NeuMo-like cells following chemotherapy represents a conserved immunoregulatory feedback mechanism with potential impact on tumor response to chemoimmunotherapy.

Supplemental material

View

Version history
  • Version 1 (April 7, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts